Home > Insider Trading > Filing (0001104659-24-047894)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1819576	Liquidia Corp	LQDA	Pharmaceutical Preparations (2834)	851710962

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1854414	Russell Schundler	419 Davis Drive, Suite 100 Morrisville NC 27560	General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-04-12	2,060	$14.58	486,027	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	14,500	Indirect	By Spouse

Footnotes

Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
These shares of common stock were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on January 11, 2023.
Includes (i) 71,615 unvested RSUs of the 104,167 RSUs granted to the Reporting Person on January 11, 2023, (ii) 110,135 unvested RSUs granted to the Reporting Person on January 11, 2024, none of which have vested as of the date of this Form 4 and (iii) 8,342 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.